Key points
- The Advisory Committee on Immunization Practices (ACIP) develops recommendations on how to use vaccines to control disease in the United States.
- These recommendations become official CDC policy once adopted by CDC's Director.
- Learn about current and historical ACIP recommendations for polio vaccine.
Published in Morbidity and Mortality Weekly Report (MMWR)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
CURRENT Polio Vaccine Recommendations
- MMWR, December 8, 2023, 72(49);1327–1330
Use of Inactivated Polio Vaccine Among U.S. Adults: Updated Recommendations of the ACIP — United States, 2023 - MMWR, August 7, 2009, Vol 58(30);829-830
Updated Recommendations of the ACIP Regarding Routine Poliovirus Vaccination - MMWR, May 19, 2000, Vol 49(RR-05);1-22
Poliomyelitis Prevention in the United States - See also:
ARCHIVED Historical Polio Immunization Publications
For your convenience, these archived publications can be used for historical and research purposes.
- MMWR, March 14, 2003, Vol 52(10);203-204
Notice to Readers: FDA Licensure of DTaP, HepB, and Polio Combined (PEDIARIX™) for Use in Infants